DaVita DVA U S Dialysis — G&A

Similar metrics at other companies

ALife Sciences and Diagnostics Markets — Selling, General and Administrative Expense

$170M+8.3%

DDHealthcare & Water Technologies — Selling, general and administrative expenses

$93M+9.4%

RKTDirect to Consumer — General and administrative expenses

$168M+115%

RVTYDiagnostics — Segment Selling, general and administrative expenses

$90.19M+0.3%

SOLVDental Solutions — Operating expenses

$148M+12.1%

FTVAdvanced Healthcare Solutions — Operating expenses

-$159M-1.7%

Questions, answered.

What is DaVita's u s dialysis — G&A?

DaVita (DVA) reported u s dialysis — G&A of $313.32M in Q4 2025.

How has DaVita's u s dialysis — G&A changed year-over-year?

DaVita's u s dialysis — G&A increased by 6.8% year-over-year, from $293.5M to $313.32M.

What is the long-term trend for DaVita's u s dialysis — G&A?

Over 3 years (2022 to 2025), DaVita's u s dialysis — G&A has grown at a 6.5% compound annual growth rate (CAGR), from $1.04B to $1.25B.

What does u s dialysis — G&A mean?

The indirect costs of managing and supporting the dialysis business operations.

How do you interpret u s dialysis — G&A?

A rising ratio of G&A to revenue may indicate administrative bloat, while a falling ratio suggests economies of scale.

How does u s dialysis — G&A compare across companies?

Standard operating expense category across all industries.